Janux Therapeutics, Inc. (JANX) on GreekSoup https://greeksoup.ai/stocks/us/janx/ Every dated entry in the public record on Janux Therapeutics, Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Fri, 30 Oct 2026 00:00:00 +0000 Janux Therapeutics, Inc.: short interest 5,327,163 shares at the 15 October 2026 settlement, 6.20 days to coverhttps://greeksoup.ai/stocks/us/janx/short-interest/us:JANX:short-interest:2026-10-15:27c2ae5fa6Thu, 15 Oct 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Janux Therapeutics, Inc.: short interest 5,684,346 shares at the 30 September 2026 settlement, 5.86 days to coverhttps://greeksoup.ai/stocks/us/janx/short-interest/us:JANX:short-interest:2026-09-30:cd2a29b020Wed, 30 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Janux Therapeutics, Inc.: short interest 5,891,965 shares at the 15 September 2026 settlement, 5.89 days to coverhttps://greeksoup.ai/stocks/us/janx/short-interest/us:JANX:short-interest:2026-09-15:91ce57f127Tue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Janux Therapeutics, Inc.: short interest 6,063,535 shares at the 31 August 2026 settlement, 7.81 days to coverhttps://greeksoup.ai/stocks/us/janx/short-interest/us:JANX:short-interest:2026-08-31:59c4cb11f9Mon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Janux Therapeutics, Inc.: Schedule 13G/A filed by Point72 Asset Management, L.P., 3.3% of the classhttps://greeksoup.ai/stocks/us/janx/holders/us:JANX:schedule-13:2026-08-14:33ddad4a98Fri, 14 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Janux Therapeutics, Inc.: short interest 6,626,696 shares at the 14 August 2026 settlement, 10.90 days to coverhttps://greeksoup.ai/stocks/us/janx/short-interest/us:JANX:short-interest:2026-08-14:c962ab5f04Fri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Janux Therapeutics, Inc.: Schedule 13G/A filed by JANUS HENDERSON GROUP Ltd., 0.3% of the classhttps://greeksoup.ai/stocks/us/janx/holders/us:JANX:schedule-13:2026-08-13:d1dd81aa9bThu, 13 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Janux Therapeutics, Inc. Q2 FY2026 results: revenue $10 million, net income -$22 millionhttps://greeksoup.ai/stocks/us/janx/results/fy2026-q2/us:JANX:result:2026-08-06:5c2fcb3637Thu, 06 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Janux Therapeutics, Inc. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/janx/filings/us:JANX:filing:2026-08-06:a7dce472deThu, 06 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Janux Therapeutics, Inc. filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/janx/filings/us:JANX:filing:2026-08-06:45e64328faThu, 06 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]>